Exploring the role of m6A modification in cancer

被引：13
|
作者：
Wei, Yongqi [1 ]
Li, Yin [1 ]
Lu, Chunlai [1 ,2 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China
来源：
PROTEOMICS | 2023年 / 23卷 / 13-14期
基金：
上海市自然科学基金;
关键词：
cancer; disease mechanisms; post-translational modifications; methods; SINGLE-NUCLEOTIDE-RESOLUTION; MESSENGER-RNA STABILITY; PROMOTES GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; TRANSLATION; METTL14; PROGRESSION; SUPPRESSES; DIFFERENTIATION; DEMETHYLATION;
D O I：
10.1002/pmic.202200208
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
m6A is one of the most common, abundant, and conserved post-transcriptional modifications that regulate broad biological processes in the human body through m6A regulators. m6A regulators are figuratively classified according to their functions: writers, erasers, and readers, which can methylate RNAs, demethylate RNAs, and recognize RNA m6A sites, consequently affecting RNA fate. Tumors are an essential class of diseases that threaten human health, and as the study of m6A modification in tumors continues to advance, more and more relevant studies are emerging. In this review, we overview the recent studies of m6A in various types of tumors to demonstrate the role of m6A modification in providing a vision in diagnosing and treating tumors.
引用
收藏
页数：18
相关论文
共 50 条
  • [41] Diverse molecular functions of m6A mRNA modification in cancer
    Han, Seung Hun
    Choe, Junho
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (05) : 738 - 749
  • [42] m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis
    Hu, Tianrui
    Wang, Guowei
    Wang, Dong
    Deng, Youwen
    Wang, Weiguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 145
  • [43] Aberrant Regulation of mRNA m6A Modification in Cancer Development
    Luo, Junyun
    Liu, Hui
    Luan, Siyu
    He, Chongsheng
    Li, Zhaoyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [44] Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
    Zhang, Lele
    Qiao, Yiting
    Huang, Jiacheng
    Wan, Dalong
    Zhou, Lin
    Lin, Shengzhang
    Zheng, Shusen
    FRONTIERS IN MEDICINE, 2020, 7
  • [45] m6A mRNA methylation: A pleiotropic regulator of cancer
    Muthusamy, Srinivasan
    GENE, 2020, 736
  • [46] Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects
    Alam, Shahil
    Giri, Pankaj Kumar
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] METTL3's role in cervical cancer development through m6A modification
    Liu, Yuqiu
    Li, Changzhong
    Deng, Qianqian
    Ren, Xingye
    Wang, Hongqing
    FASEB JOURNAL, 2024, 38 (11)
  • [48] Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma
    Zhang, Yujie
    Wang, Yanyan
    Ying, Liwei
    Tao, Sifeng
    Shi, Mingmin
    Lin, Peng
    Wang, Yangxin
    Han, Bin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] The current landscape of m6A modification in urological cancers
    Zeng, Yaohui
    Lv, Cai
    Wan, Bangbei
    Gong, Binghao
    PEERJ, 2023, 11
  • [50] The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications
    Yu, Mengjiao
    Ji, Wenqian
    Yang, Xu
    Tian, Kai
    Ma, Xinyi
    Yu, Shali
    Chen, Lin
    Zhao, Xinyuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345